B2B tech platform Grinta raised $8 million in SEED co-led by Raed Ventures and Nclude

Share via:

Cairo-based Fintech-enabled B2B tech platform Grinta raised $8 million in SEED co-led by Raed Ventures and Nclude where other investors include Silicon Valley-based Endeavor Catalyst and 500 Global also participated.

Grinta is a managed marketplace that empowers independent pharmacies to modernise the pharmaceutical supply chain. Grinta is collaborating with all value chain stakeholders, including manufacturers, distributors, wholesalers, and pharmacies, to create a data-driven, dependable, and efficient pharmaceutical supply chain. The investment will be directed toward scaling Grinta’s full-stack tech platform, expanding the team, and accelerating growth across the Egyptian market by the Fintech-enabled B2B tech platform digitising the pharmaceutical supply chain.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

B2B tech platform Grinta raised $8 million in SEED co-led by Raed Ventures and Nclude

Cairo-based Fintech-enabled B2B tech platform Grinta raised $8 million in SEED co-led by Raed Ventures and Nclude where other investors include Silicon Valley-based Endeavor Catalyst and 500 Global also participated.

Grinta is a managed marketplace that empowers independent pharmacies to modernise the pharmaceutical supply chain. Grinta is collaborating with all value chain stakeholders, including manufacturers, distributors, wholesalers, and pharmacies, to create a data-driven, dependable, and efficient pharmaceutical supply chain. The investment will be directed toward scaling Grinta’s full-stack tech platform, expanding the team, and accelerating growth across the Egyptian market by the Fintech-enabled B2B tech platform digitising the pharmaceutical supply chain.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at [email protected]

More like this

‘Embarrassing and wrong’: Google admits it lost control of...

Google has apologized (or come very close to...

Virtual Staging AI helps Realtors digitally furnish rooms within...

House staging is a significant part of the...

Treating a chatbot nicely might boost its performance —...

People are more likely to do something if...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!